1 / 21

Hepatocutaneous Syndrome

Hepatocutaneous Syndrome. Maura St. John Ultrasound Rotation Block 19 - 2007. Signalment. Shelton - 12-year-old MC Shetland Sheepdog. Presentation. Seen by Dermatology Evaluation of skin problems mainly affecting the paws & paw pads

yepa
Download Presentation

Hepatocutaneous Syndrome

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hepatocutaneous Syndrome Maura St. John Ultrasound Rotation Block 19 - 2007

  2. Signalment Shelton - 12-year-old MC Shetland Sheepdog

  3. Presentation • Seen by Dermatology • Evaluation of skin problems mainly affecting the paws & paw pads • beginning in September 2006 as hardening, enlarged paw pads

  4. Clinical Signs • beginning in September 2006 as hardening, enlarged paw pads • lethargy & inappetence, attributed to the pain associated with the paw pads by the rDVM

  5. Previous Diagnostics • ChemPanel • Increased liver enzymes (ALP, GGT, ALT, AST) • Biopsy • Moderate parakeratosis with irregular epidermal hyperplasia & increased basophilia • Suggestive of superficial necrolytic dermatitis with secondary pyoderma

  6. Previous Treatments • Antibiotics -- Clavamox • No response • Prednisone • Helped paw pads • Helped appetite • Currently on a 1mg/kg dosage EOD

  7. Dermatological Examination • All four paw pads are hyperkeratinized with excessive scaling/crusting, especially around the edges of the paws • Few fissures on the paw pads & interdigital accumulation of the hyperkeratoic material is obvious on all paws

  8. Physical Examination • T 101.7, P 110, R 30. • PLN: Left popliteal LN mildly enlarged • EENT: Cataracts OU, diminished PLRs OU. • GI/GU: Unremarkable. • MSN: Unremarkable. • CV/P: Unremarkable.

  9. VTH Diagnostics • Bile acids tolerance test: • Pre: 6.2 • Post: 15.9 • Abdominal ultrasound: ….

  10. Hyperechoic adrenal nodule • Adenoma • Hyperplasia

  11. Pancreatic Nodule

  12. Liver • Generally enlarged • Diffuse lacy appearance • Irregularly shaped hypoechoic nodules/foci separated by thin, hyperechoic tissue

  13. HEPATOCUTANEOUS SYNDROME • Superficial necrolytic dermatitis • Metabolic epidermal necrosis • Necrolytic migratory erythema

  14. The “Swiss Cheese” Liver • Ultrasound exam may demonstrate a pancreatic tumor or a honeycomb or Swiss cheese appearance to the liver because a hyperechoic network surrounds hypoechoic areas of parenchyma. Histologically, the hypoechoic regions correspond to distinct regenerative nodules bounded by severely vacuolated (fat-laden) hepatocytes, numerous bile ductules, and a network of reticulin and fine collagen fibers representing remnants of collapsed hepatic lobules.

  15. So, what causes this? • The pathogenesis is not completely understood. It is believed that deficiencies in certain nutrients (e.g., amino acids, biotin, essential fatty acids, zinc) probably cause keratinocyte degeneration. The most common pathologic association is liver disease, although diabetes mellitus and pancreatic tumors have also been reported. Chronic administration of phenobarbital may also be a risk factor for the development of SND.

  16. FNA • A fine-needle aspirate or ultrasound-guided biopsy sample from the liver may be either helpful or misleading. • vacuolar hepatopathy • ballooning degeneration This may be interpreted as fatty infiltration or steroid hepatopathy, especially if the animal has been on prior glucocorticoid therapy for the presenting clinical complaints.

  17. Specific Treatment • Amino Acids • 8.5% without electrolytes • Central venous catheter infused slowly (80mL/hour) • Repeated every 2 weeks until resolution of signs • Then, as needed

  18. Supportive Treatments • Vitamin K • 1mg/kg q 7 days • subcutis • Vitamin B • 50mcg/kg twice in 2-week interval • Then continued monthly • Zinc gluconate -- 5mg/kg SID • SAM-e -- 18mg/kg SID • DIET: high in essential fatty acids (Eukanuba FP)

More Related